<DOC>
	<DOCNO>NCT01609205</DOCNO>
	<brief_summary>The purpose study relationship RA disease activity base Doppler quantification subsequent clinical response ( EULAR response ) treatment Adalimumab 12 month . The purpose also compare Doppler quantification conventional clinical method semiquantitative Doppler assessment .</brief_summary>
	<brief_title>Doppler Evaluation RA Patients After Adalimumab .</brief_title>
	<detailed_description />
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Adult patient ( &gt; 18 year age ) , male female Rheumatoid arthritis accord 1987 ACR 2010 EULAR/ACR classification criterion Moderate high disease activity Ongoing antirheumatic treatment DMARD , stable dosage last 3 month , candidate antiTNF addon therapy OR ongoing treatment first antiTNF therapy candidate switch another antiTNF therapy Women childbearing potential : use adequate method contraception avoid pregnancy throughout study Signed Informed Consent *Signed Informed Consent must obtain study specific procedure take place . Biologic treatment Adalimumab inclusion Two ongoing biologic treatment inclusion Treatment biologic treatment antiTNF therapy inclusion Any contraindication treatment Adalimumab Intraarticular corticosteroid injection last 4 week followup visit Positive tuberculosis hepatitis B . Ongoing pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>